A Two-Step Increase in Ex Vivo Total Lymphocyte Fas Surface Expression in HTLV-1-Infected Individuals and HAM/TSP Patients, Distinguishable from MS Patients. This evidence concerns the gene FAS and myeloid sarcoma.